40774 Federal Register / Vol. 83, No. 159 / Thursday, August 16, 2018 / Notices 

Public participants may submit written 

statements in advance of the scheduled 

meeting. Oral comments will be 

honored in the order they are requested 

and may be limited as time allows. 

Requests to submit a written statement 

or make oral comments to NACRHHS 

should be sent to Steven Hirsch, using 

the contact information above at least 3 

business days prior to the meeting. 

Individuals who plan to attend and 

need special assistance or another 

reasonable accommodation should 

notify Steven Hirsch at the address and 

phone number listed above at least 10 

business days prior to the meeting. 

Amy P. McNulty, 

Acting Director, Division of the Executive 

Secretariat. 

[FR Doc. 2018–17623 Filed 8–15–18; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Opportunity to Co-Sponsor Office of 

Research Integrity Workshops 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: The Office of Research 

Integrity (ORI) announces the 

opportunity for non-federal public and 

private sector entities to co-sponsor ORI 

conferences or workshops (ORI 

Workshops). Potential co-sponsors must 

have a demonstrated interest and 

experience in the responsible conduct of 

research (RCR) or the handling of 

research misconduct allegations. 

Potential co-sponsors must be willing to 

participate substantively in the cosponsored activity. 

Expressions of interest for cosponsorships of ORI Workshops are 

received throughout the year at the 

email address below. ORI co-sponsors a 

limited number of workshops with other 

entities each year. Expressions of 

interest are being received for ORI 

Workshops that will take place in the 

next fiscal year (October 2018 through 

September 2019) or beyond. 

Expressions of interest for cosponsorships should be sent by email to 

AskORI@HHS.GOV with ‘‘Cosponsorship for ORI Workshops’’ in the 

subject field or by mail to ORI at 1101 

Wootton Parkway, Suite 750, Rockville, 

MD 20852. 

FOR FURTHER INFORMATION CONTACT: 

Tracey Randolph, Program Analyst, 

Office of Research Integrity, 1101 

Wootton Parkway, Suite 750, Rockville, 

MD 20852, (240) 453–8200. 

SUPPLEMENTARY INFORMATION: ORI 

oversees and directs U.S. Public Health 

Service (PHS) research integrity 

activities on behalf of the Secretary of 

U.S. Department of Health and Human 

Services (HHS), with the exception of 

the regulatory research integrity 

activities of the Food and Drug 

Administration. ORI is a program office 

within the Office of the Assistant 

Secretary for Health, Office of the 

Secretary, HHS. 

ORI’s Division of Education and 

Integrity (DEI) has among its duties the 

responsibility to develop and 

implement activities and programs to 

teach RCR and train Research Integrity 

Officers (RIOs) as well as others that are 

involved in research integrity, such as 

Institutional Officials (IOs) and 

institutional counsel. 

Consistent with ORI’s mission and the 

applicable statutory authority, 42 U.S.C. 

289b, ORI Workshops aim to provide 

clarification and technical information 

on the HHS regulations for handling 

research misconduct allegations and on 

education in RCR to foster integrity in 

research. ORI Workshops are 

moderately sized, convening over one to 

three days, and typically accepting 

between 20 and 50 attendees. 

Co-sponsors will assist with 

workshop and agenda development, 

coordination, financial management, 

and meeting logistics in conjunction 

with ORI staff. 

Co-sponsors can charge registration 

fees to recover costs associated with the 

events; however, co-sponsors may not 

set registration fees at an amount higher 

than necessary to recover related event 

expenses. Further, co-sponsors are 

solely responsible for collecting and 

handling any registration fees collected. 

Eligibility for Co-Sponsorship: The cosponsoring entity must have a 

demonstrated interest and experience in 

the RCR or the handling of research 

misconduct allegations. The cosponsoring entity must participate 

substantively in the co-sponsored 

activity, not just provide funding or 

logistical support. 

Each co-sponsorship expression of 

interest shall describe: (1) The entity’s 

interest and goals in promoting research 

integrity or the RCR, (2) the entity’s 

prior experience and current readiness 

to undertake the responsibilities 

described above, (3) the type of event(s) 

that the entity is interested in cosponsoring with ORI, (4) facilities 

available for the event(s), and (5) any 

current constraints with respect to dates 

or facilities. The type of event may be 

an event from ORI’s regular program of 

recurring events (e.g., RCR Instructor’s 

Workshop) or a special topic of mutual 

interest to be developed jointly. The 

expression of interest should be a 

bulleted outline, no more than two 

pages in length, single-spaced, and 11- 

point font. An entity may submit an 

expression of interest individually or 

jointly with other entities describing 

their relative contributions. 

Evaluation Criteria: After engaging in 

exploratory discussions with potential 

co-sponsors that respond to this notice, 

the following considerations will be 

used by HHS officials, as appropriate 

and relevant, to select the co-sponsor(s): 

• Qualifications and capability to fulfill 

co-sponsorship responsibilities 

• suitability of the location of the 

proposed event in terms of the overall 

geographical distribution of ORI 

events 

• potential for reaching, generating, and 

engaging adequate number of 

attendees from stakeholders 

• availability and description of 

facilities needed to support the 

workshop 

• availability of administrative support 

for the logistics of hosting such 

workshops 

The selected co-sponsoring 

organization(s) shall furnish the 

necessary personnel, materials, services, 

and facilities to administer its 

responsibility for the workshop. These 

duties will be outlined in a cosponsorship agreement with ORI that 

will set forth the details of the cosponsored activity, including the 

requirements that any fees collected by 

the co-sponsor shall be limited to the 

amount necessary to cover the cosponsor’s related event expenses. This 

co-sponsorship agreement does not 

represent an endorsement by ORI of an 

individual co-sponsor’s policies, 

positions, or activities. Additionally, 

this agreement will not affect any 

determination concerning activities by 

the co-sponsors that are regulated by 

ORI. 

Dated: August 9, 2018. 

Scott J. Moore, 

Deputy Director, Office of Research Integrity. 

[FR Doc. 2018–17615 Filed 8–15–18; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the Advisory Committee on 

Blood and Tissue Safety and 

Availability 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health. 


sradovich on DSK3GMQ082PROD with NOTICES